Joshua A Kazam
CIK 1221355 · President & CEO · last filed 2026-06-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ALLO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
12TH FLOOR
NEW YORK, NY 10022
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALLO | Director | 398,463 | $1.21 | $482.1K | $189.0K | 20 | 2026-06-23 |
| Kronos Bio, Inc. (KRON) Delisted | Director | 0 | $0.88 | $0 | $0 | 7 | 2025-06-20 |
| Latch, Inc. (TSIAW) Delisted | 30,000 | $2.42 | $72.6K | $0 | 1 | 2021-06-07 | |
| Tishman Speyer Innovation Corp. II (TSIBU) Delisted | Director | 25,000 | $10.04 | $251.0K | $0 | 1 | 2021-02-16 |
| DraftKings Holdings Inc. (DEACW) Delisted | Director | — | — | — | $0 | 1 | 2019-12-31 |
| Target Hospitality Corp. (EAGLW) Delisted | Director | 10,000 | — | — | $101.7K | 3 | 2019-03-05 |
| Target Hospitality Corp. (EAGLU) Delisted | Director | — | — | — | $0 | 1 | 2018-01-18 |
| CAPR | Director | — | $5.74 | — | $0 | 3 | 2018-01-04 |
| Kite Pharma, Inc. (KITE) Delisted | Director | 4,360 | — | — | $0 | 3 | 2017-06-22 |
| CAPRICOR THERAPEUTICS, INC. (NLTXW) Delisted | Chief Executive Officer | 1,493,758 | — | — | $0 | 3 | 2011-05-12 |
| CAPRICOR THERAPEUTICS, INC. (NLTX) Delisted | Chief Executive Officer | 1,444 | $13.96 | $20.2K | $15.9K | 8 | 2009-07-23 |
Recent Filings · Page 4 of 6
59 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-03-01 | Target Hospitality Corp. (EAGLW) Delisted | Buy (P) | +5,000 | $50.7K | EDGAR |
| 2019-01-22 | Target Hospitality Corp. (EAGLW) Delisted | Buy (P) | — | $0 | EDGAR |
| 2018-10-17 | ALLO | Conv (C) | +18,716 | $0 | EDGAR |
| 2018-01-18 | Target Hospitality Corp. (EAGLU) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-04 | CAPR | Grant (A) | — | $0 | EDGAR |
| 2017-10-05 | — | Mixed | −4,360 | -$13.07M | |
| 2017-06-22 | Kite Pharma, Inc. (KITE) Delisted | Grant (A) | +2,410 | $0 | EDGAR |
| 2017-01-04 | CAPR | Grant (A) | — | $0 | EDGAR |
| 2016-06-06 | CAPR | Grant (A) | — | $0 | EDGAR |
| 2016-06-03 | Kite Pharma, Inc. (KITE) Delisted | Grant (A) | +1,950 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.